These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50. Mg2+ dependence of Ca2+ release from the sarcoplasmic reticulum induced by sevoflurane or halothane in skeletal muscle from humans susceptible to malignant hyperthermia. Duke AM; Hopkins PM; Halsall PJ; Steele DS Br J Anaesth; 2006 Sep; 97(3):320-8. PubMed ID: 16849381 [TBL] [Abstract][Full Text] [Related]
51. Calcium release from sarcoplasmic reticulum is facilitated in human myotubes derived from carriers of the ryanodine receptor type 1 mutations Ile2182Phe and Gly2375Ala. Wehner M; Rueffert H; Koenig F; Olthoff D Genet Test; 2003; 7(3):203-11. PubMed ID: 14641996 [TBL] [Abstract][Full Text] [Related]
52. Measurement of resting cytosolic Ca2+ concentrations and Ca2+ store size in HEK-293 cells transfected with malignant hyperthermia or central core disease mutant Ca2+ release channels. Tong J; McCarthy TV; MacLennan DH J Biol Chem; 1999 Jan; 274(2):693-702. PubMed ID: 9873004 [TBL] [Abstract][Full Text] [Related]
53. Altered mRNA splicing of the skeletal muscle ryanodine receptor and sarcoplasmic/endoplasmic reticulum Ca2+-ATPase in myotonic dystrophy type 1. Kimura T; Nakamori M; Lueck JD; Pouliquin P; Aoike F; Fujimura H; Dirksen RT; Takahashi MP; Dulhunty AF; Sakoda S Hum Mol Genet; 2005 Aug; 14(15):2189-200. PubMed ID: 15972723 [TBL] [Abstract][Full Text] [Related]
54. Association of a mutation in the ryanodine receptor 1 gene with equine malignant hyperthermia. Aleman M; Riehl J; Aldridge BM; Lecouteur RA; Stott JL; Pessah IN Muscle Nerve; 2004 Sep; 30(3):356-65. PubMed ID: 15318347 [TBL] [Abstract][Full Text] [Related]
56. Distinct effects on Ca2+ handling caused by malignant hyperthermia and central core disease mutations in RyR1. Dirksen RT; Avila G Biophys J; 2004 Nov; 87(5):3193-204. PubMed ID: 15347586 [TBL] [Abstract][Full Text] [Related]
57. Peptide probe study of the role of interaction between the cytoplasmic and transmembrane domains of the ryanodine receptor in the channel regulation mechanism. Hamada T; Bannister ML; Ikemoto N Biochemistry; 2007 Apr; 46(14):4272-9. PubMed ID: 17361990 [TBL] [Abstract][Full Text] [Related]
58. Ryanodine receptor mutations in malignant hyperthermia and central core disease. McCarthy TV; Quane KA; Lynch PJ Hum Mutat; 2000; 15(5):410-7. PubMed ID: 10790202 [TBL] [Abstract][Full Text] [Related]
59. Calcium pool size modulates the sensitivity of the ryanodine receptor channel and calcium-dependent ATPase of heavy sarcoplasmic reticulum to extravesicular free calcium concentration. Marie V; Silva JE J Cell Physiol; 1998 Jun; 175(3):283-94. PubMed ID: 9572473 [TBL] [Abstract][Full Text] [Related]
60. Interaction of S100A1 with the Ca2+ release channel (ryanodine receptor) of skeletal muscle. Treves S; Scutari E; Robert M; Groh S; Ottolia M; Prestipino G; Ronjat M; Zorzato F Biochemistry; 1997 Sep; 36(38):11496-503. PubMed ID: 9298970 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]